Le Lézard
Classified in: Health
Subject: BFA

Olympus Announces New Endoscope Reprocessing Technology


CENTER VALLEY, Pa., Oct. 1, 2020 /PRNewswire/ -- Olympus, a global technology leader in designing and delivering innovative solutions for medical and surgical procedures, announced today the market availability of the OER-Elite, its next-generation automated endoscope reprocessor (AER). Cleaning and reprocessing of endoscopes between cases is vital to patient safety, and postmarket research on reprocessing endoscopes shows that automation improves the effectiveness of this process.

The OER-Elite simultaneously cleans and disinfects up to two endoscopes in 28 minutes. High-level disinfection is accomplished using Acecide-C®, a peracetic acid-based disinfectant. The system also offers a cleaning cycle, using a combination of EndoQuick alkaline detergent and ultrasonic cleaning. Research shows that this combination is the most effective way to remove foreign matter from the endoscope surface.i

For more information about the OER-Elite, visit: medical.olympusamerica.com/oer-elite

"Infection prevention is critical to patient safety. With the OER-Elite, healthcare providers have an efficient and effective means to consistently clean and disinfect their endoscopes and help ensure those scopes are available for physicians when needed," says Kevin Mancini, Group Vice President for Endoscopy, Olympus America Inc. "Olympus continues to innovate its products to not only meet the needs of our current healthcare environment but also increase automation, improve quality of care, and enhance patient satisfaction." 

The OER-Elite is compatible with Olympus endoscopes, including the new TJF-Q190V duodenoscope, through its distal connector for endoscopes with forceps elevators.  Other new design features of the OER-Elite resulted from human factors studies. These include:

Medical societies including the Society for Gastointestinal Nurses and Associates (SGNA) and the American Society for Gastroenterology (ASGE) recognize and recommend the use of an AER to standardize processes, improve reprocessing efficacy, and reduce personnel exposure to high-level disinfectants.ii,iii

About Olympus
Olympus is passionate about the solutions it creates for the medical, life sciences, and industrial equipment industries, as well as cameras and audio products.

Olympus' Medical business uses innovative capabilities in medical technology, therapeutic intervention, and precision manufacturing to help healthcare professionals deliver diagnostic, therapeutic, and minimally invasive procedures to improve clinical outcomes, reduce overall costs, and enhance the quality of life for patients. Olympus' Medical portfolio includes endoscopes, laparoscopes, and video imaging systems, as well as surgical energy devices, system integration solutions, medical services, and a wide range of endotherapy instruments. For more information, visit www.olympus-global.com.

i Muscarella, L.F. The Benefits of Ultrasonic Cleaning. Infection Control Today. https://www.infectioncontroltoday.com/environmental-hygiene/benefits-ultrasonic-cleaning. Published May 1, 2001. Accessed September 24, 2020.
ii SGNA: Standards of Infection Prevention in Reprocessing Flexible Endoscopes, 2018.  SGNA.org. https://www.sgna.org/Portals/0/SGNA%20Standards%20of%20infection%20prevention%20in%20reprocessing_FINAL.pdf?ver=2018-11-16-084835-387. Accessed September 24, 2020.
iii Multisociety guideline on reprocessing flexible gastrointestinal endoscopes: 2016. Gastrointest Endosc 2017;85:282?294.e1. DOI: http://dx.doi.org/10.1016/j.gie.2016.10.002.

SOURCE Olympus Medical Systems Group


These press releases may also interest you

at 22:03
The report titled "Anti-Mullerian Hormone Test Market by Product (POC Testing, Self-check Kits), End-User (Commercial Labs, Research & development), Distribution, Use - Global Forecast 2024-2030" is now available on 360iResearch.com's offering,...

at 20:40
Rakovina Therapeutics Inc. a biopharmaceutical company committed to advancing new cancer therapies based on novel DNA-damage response technologies announced the financial results for its fourth quarter and fiscal year ending December 31, 2023 and...

at 19:40
ReNAgade Therapeutics, a company unlocking the limitless potential for RNA medicines, today announced its ongoing commitment to exploring the therapeutic opportunity of glycobiology through support for ongoing research at GanNA Bio, and the...

at 19:05
Appili Therapeutics Inc. (the "Company" or "Appili"), a biopharmaceutical company focused on drug development for infectious diseases and medical countermeasures, today announced it has secured additional bridge financing in the amount of C$300,000...

at 19:00
David J. Dykeman, co-chair of the Life Sciences & Medical...

at 18:30
Aspire Health Alliance ("Aspire Health") is a company headquartered in Braintree, Massachusetts, that provides behavioral health services in the community.  Aspire Health experienced a data security incident that may have involved personal and...



News published on and distributed by: